|
Basis of Presentation and Significant Accounting Policies (Details Narrative) (USD $)
|
3 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2015
Breathlyzers
|
Mar. 31, 2014
|
Jun. 30, 2014
|
Dec. 31, 2014
|
|
| Allowance for doubtful accounts receivable | $ 0us-gaap_AllowanceForDoubtfulAccountsReceivable | $ 0us-gaap_AllowanceForDoubtfulAccountsReceivable | ||
| Cash on hand, pending deposit | 37,067aker_CashOnHandPendingDeposit | |||
| Accounts receivable | 1,000,000us-gaap_AccountsReceivableNet | 1,000,000us-gaap_AccountsReceivableNet | ||
| Number of patents | 9aker_NumberOfPatents | |||
| Investment in Hainan Savy Akers Biosciences, Ltd. joint venture | 64,675us-gaap_PaymentsToAcquireInterestInJointVenture | |||
| Percentage of ownership in Hainan Savy Akers Biosciences, Ltd. joint venture | 19.90%us-gaap_EquityMethodInvestmentOwnershipPercentage | |||
| Revenue from related parties | 766,379us-gaap_RevenueFromRelatedParties | |||
| Shipping, handling and transportation costs | 18,941us-gaap_ShippingHandlingAndTransportationCosts | 8,238us-gaap_ShippingHandlingAndTransportationCosts | ||
| Net Loss Attributable to Common Stockholders | 1,321,799us-gaap_NetIncomeLoss | 595,600us-gaap_NetIncomeLoss | ||
| Option [Member] | ||||
| Antidilutive securities excluded from computation of earnings per share |
175,000us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount / us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis = us-gaap_OptionMember |
|||
| Warrant [Member] | ||||
| Antidilutive securities excluded from computation of earnings per share |
1,989us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount / us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis = us-gaap_WarrantMember |
|||
| June 25, 2015 [Member] | ||||
| Accounts receivable |
864,000us-gaap_AccountsReceivableNet / us-gaap_CreationDateAxis = aker_JuneTwentyFiveTwothousandFifteenMember |
|||
| Increment One Paid on April 30, 2015 [Member] | ||||
| Accounts receivable |
500,000us-gaap_AccountsReceivableNet / us-gaap_PlanNameAxis = aker_IncrementOnePaidOnAprilThirtyTwentyFifteenMember |
|||
| Increment Two Paid on July 30, 2015 [Member] | ||||
| Accounts receivable |
500,000us-gaap_AccountsReceivableNet / us-gaap_PlanNameAxis = aker_IncrementTwoPaidOnJulyThirtyTwentyFifteenMember |
|||
| Sales [Member] | ||||
| Concentration risk percentage |
66.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_SalesMember |
|||
| Concentration risk, number of customer |
2aker_ConcentrationRiskNumberOfCustomer / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_SalesMember |
|||
| Trade Receivable [Member] | ||||
| Concentration risk percentage |
4.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_TradeAccountsReceivableMember |
|||
| Concentration risk, number of customer |
2aker_ConcentrationRiskNumberOfCustomer / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_TradeAccountsReceivableMember |
|||
| Cost of Sales [Member] | ||||
| Shipping, handling and transportation costs |
44,690us-gaap_ShippingHandlingAndTransportationCosts / us-gaap_IncomeStatementLocationAxis = us-gaap_CostOfSalesMember |
11,037us-gaap_ShippingHandlingAndTransportationCosts / us-gaap_IncomeStatementLocationAxis = us-gaap_CostOfSalesMember |
||
| Fulton Bank of New Jersey [Member] | ||||
| Cash |
210,771us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_FultonBankOfNewJerseyMember |
399,417us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_FultonBankOfNewJerseyMember |
||
| Bank of America [Member] | ||||
| Cash |
82,954us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_BankOfAmericaMember |
52,384us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_BankOfAmericaMember |
||
| PayPal [Member] | ||||
| Cash |
4,040us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_PayPalMember |
4,040us-gaap_Cash / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_PayPalMember |
||
| Rapid Enzymatic Assay [Member] | ||||
| Revenue from related parties |
864,000us-gaap_RevenueFromRelatedParties / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = aker_RapidEnzymaticAssayMember |
|||
| Minimum [Member] | ||||
| Normal credit terms extended to customers | 30 days | |||
| Maximum [Member] | ||||
| Normal credit terms extended to customers | 90 days | |||
| Cash, FDIC insured amount |
$ 250,000us-gaap_CashFDICInsuredAmount / us-gaap_RangeAxis = us-gaap_MaximumMember |
|||
| Maximum [Member] | Patents [Member] | ||||
| Finite-lived intangible asset, useful life | 17 years | |||
| X | ||||||||||
|
- Definition
Cash on hand, pending deposit. No definition available.
|
| X | ||||||||||
|
- Definition
Concentration risk number of customer. No definition available.
|
| X | ||||||||||
|
- Definition
Normal credit terms extended to customers. No definition available.
|
| X | ||||||||||
|
- Definition
Number of patents. No definition available.
|
| X | ||||||||||
|
- Definition
For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
| X | ||||||||||
|
- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Cost incurred during the reporting period in transporting goods and services to customers. Includes freight-out costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|